Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
Clinical trial NCT02032901 · COMPLETED
Trial details
- NCT number
- NCT02032901
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-09-01
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.